| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Tammenoms Bakker Juliet | Director | C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO | /s/ Robert L. Wernli, Jr., as Attorney-in-Fact | 04 Jun 2025 | 0001431159 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RXST | Common Stock | Award | +10,752 | +29% | 48,146 | 03 Jun 2025 | Direct | F1, F2 | ||
| holding | RXST | Common Stock | 1,548 | 03 Jun 2025 | See footnote | F3 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. |
| F2 | Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 3, 2025. |
| F3 | These securities are held by a trust. The Reporting Person, a member of the Issuer's board of directors, is the Investment Trustee of such trust and may be deemed to share voting, investment and dispositive power with respect to such securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose. |